Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W D Weaver

Showing results (151-160 of 165) with videos related to

Pageof 17
Sort By:
Journal of Electrocardiology|January 1, 1997
Admission prediction of expected final myocardial infarct size using weighted ST-segment, Q wave, and T wave measurementsM L Wilkins, C Maynard, B H Annex, et al.
Stroke|March 20, 1998
Thrombolysis-related intracranial hemorrhage: a radiographic analysis of 244 cases from the GUSTO-1 trial with clinical correlation. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary ArteriesJ M Gebel, C A Sila, M A Sloan, et al.
Journal of the American College of Cardiology|November 18, 2000
A randomized trial of the effects of early cardiac serum marker availability on reperfusion therapy in patients with acute myocardial infarction: the serial markers, acute myocardial infarction and rapid treatment trial (SMARTT)W B Gibler, J W Hoekstra, W D Weaver, et al.
Circulation|October 7, 1998
Prediction of 30-day mortality among patients with thrombolysis-related intracranial hemorrhageM A Sloan, C A Sila, K W Mahaffey, et al.
Circulation|January 26, 1999
Effects of stroke on medical resource use and costs in acute myocardial infarction. GUSTO I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries StudyC Y Tung, C B Granger, M A Sloan, et al.
Circulation|October 15, 1996
Age and outcome with contemporary thrombolytic therapy. Results from the GUSTO-I trial. Global Utilization of Streptokinase and TPA for Occluded coronary arteries trialH D White, G I Barbash, R M Califf, et al.
Circulation|November 1, 1996
ACC/AHA guidelines for the management of patients with acute myocardial infarction: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction)T J Ryan, J L Anderson, E M Antman, et al.
Journal of the American College of Cardiology|November 1, 1996
ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction)T J Ryan, J L Anderson, E M Antman, et al.
Journal of the American College of Cardiology|January 1, 1997
Gender and acute myocardial infarction: is there a different response to thrombolysis?S L Woodfield, C F Lundergan, J S Reiner, et al.
Circulation|December 22, 1998
TNK-tissue plasminogen activator compared with front-loaded alteplase in acute myocardial infarction: results of the TIMI 10B trial. Thrombolysis in Myocardial Infarction (TIMI) 10B InvestigatorsC P Cannon, C M Gibson, C H McCabe, et al.
Pageof 17

Showing results (151-160 of 165) with videos related to

Sort By:
Pageof 17
Journal of Electrocardiology|January 1, 1997
Admission prediction of expected final myocardial infarct size using weighted ST-segment, Q wave, and T wave measurementsM L Wilkins, C Maynard, B H Annex, et al.
Stroke|March 20, 1998
Thrombolysis-related intracranial hemorrhage: a radiographic analysis of 244 cases from the GUSTO-1 trial with clinical correlation. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary ArteriesJ M Gebel, C A Sila, M A Sloan, et al.
Journal of the American College of Cardiology|November 18, 2000
A randomized trial of the effects of early cardiac serum marker availability on reperfusion therapy in patients with acute myocardial infarction: the serial markers, acute myocardial infarction and rapid treatment trial (SMARTT)W B Gibler, J W Hoekstra, W D Weaver, et al.
Circulation|October 7, 1998
Prediction of 30-day mortality among patients with thrombolysis-related intracranial hemorrhageM A Sloan, C A Sila, K W Mahaffey, et al.
Circulation|January 26, 1999
Effects of stroke on medical resource use and costs in acute myocardial infarction. GUSTO I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries StudyC Y Tung, C B Granger, M A Sloan, et al.
Circulation|October 15, 1996
Age and outcome with contemporary thrombolytic therapy. Results from the GUSTO-I trial. Global Utilization of Streptokinase and TPA for Occluded coronary arteries trialH D White, G I Barbash, R M Califf, et al.
Circulation|November 1, 1996
ACC/AHA guidelines for the management of patients with acute myocardial infarction: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction)T J Ryan, J L Anderson, E M Antman, et al.
Journal of the American College of Cardiology|November 1, 1996
ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction)T J Ryan, J L Anderson, E M Antman, et al.
Journal of the American College of Cardiology|January 1, 1997
Gender and acute myocardial infarction: is there a different response to thrombolysis?S L Woodfield, C F Lundergan, J S Reiner, et al.
Circulation|December 22, 1998
TNK-tissue plasminogen activator compared with front-loaded alteplase in acute myocardial infarction: results of the TIMI 10B trial. Thrombolysis in Myocardial Infarction (TIMI) 10B InvestigatorsC P Cannon, C M Gibson, C H McCabe, et al.
Pageof 17